Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | F9 | P00740 | 3/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21975419 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975179 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21976049 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975467 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975464 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975373 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21976050 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975181 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975698 | 0.99 | MAPT (0.36) | MAPTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL21975661 | 0.97 | MAPT (0.39) | MAPTSMN1; SMN2MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200144511-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DOOSAN CORPORATION (KR) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200144511-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, ORAI2, ORC3 | MAPT 1081/4885SMN1; SMN2 4039/4885MEN1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.